Abstract
Background and aims
Dyslipidemia is a major risk factor for macrovascular complications in patients with type 2 diabetes mellitus (T2DM) [1] . Macrovascular disease is the most common cause of morbidity and mortality in T2DM [2] , and is defined as illnesses affecting the larger arteries supplying the heart, brain and the lower limbs, thereby causing cardiovascular disease (CVD), cerebrovascular disease and peripheral vascular disease. Type 2 diabetic patients often have an atherogenic lipid profile (high triglycerides [TG] and low high-density lipoprotein cholesterol [HDL] ) which greatly increases the risk of developing CVD [3] . Early correction of dyslipidemia in this type of patients reduces cardiovascular risk [4] .
The aim of the present study was to study the lipid profile in type 2 diabetic patients and assess the importance of HbA1c as an indicator of dyslipidemia and future risk of cardiovascular disease in this group of patients.
Materials and methods
This prospective cohort study included 450 type 2 diabetic patients: 285 (63.3%) women and 165 (36.6%) men. Patients were recruited from the Internal Medicine Hospital of Ain Defla in the Western Province of Algeria between January 2011 and January 2012. Patients were subjected to physical examination and laboratory tests. Candidates with other causes of secondary dyslipidemia (hypothyroidism, Cushing disease or steroid medication use, nephrotic syndrome, etc.) and patients on lipid-controlling drugs were not included.
Blood samples were obtained after 12-hours fasting. Fasting Blood Glucose (FBG) was assessed using colorimetric enzymatic technique (Prochima), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) levels were measured with by enzymatic assays.
Total cholesterol was determined in plasma, and HDL-C was measured in the supernatant, after precipitation of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C) with dextran sulfate in magnesium chloride. LDL-C levels were estimated using the Friedewald formula: LDL-C= TC -HDL-C -TG/5. HbA1c was measured by using an ion exchange chromatography method (Crest A Coral clinical system, USA).
According to the NCEP -ATPIII guidelines, hypercholesterolemia is defined when TC > 200 mg/dl, high LDL-C when the value is over 100 mg/dl, hypertriglyceridemia if TG >150 mg/dl and low HDL-C when the value is below 40 mg/dl in men, and 50 mg/dl in women. Patients with one or more parameters (TC, TG, HDL-C, or LDL-C) outside values recommended by the NCEP-ATPIII were considered to have dyslipidemia [5] . Dyslipidemias were classified into: mixed dyslipidaemia (three abnormal lipid parameters); combined dyslipidemia (two abnormal lipid parameters) and isolated dyslipidemia (only one abnormal parameter) [6] . The impact of glycemic control on various parameters was evaluated by categorizing all patients into two groups based on their HbA1c levels. Group I (good glycemic control; HbA1c <7%) and Group II (poor glycemic control; HbA1c ≥ 7%). The selection of these cutoff values of HbA1c was based on the current American Diabetes Association recommendations for most non-pregnant adults [7] .
Statistical analysis Statistical analysis was performed using SPSS version 17.0. Pearson's correlation coefficient was used to examine the association between various continuous parameters; the linear regression model was used. Independent samples t-test was used to compare means of different variables. Data were presented as mean ± standard deviation (SD). The results were considered statistically significant when the two tailed p value was < 0.05.
Results
General characteristics of the study population are presented in Table 1 . The mean age (±S.D) was 67.72 ± 10.24 versus 45.86 ± 12.08 years in males and females, respectively. The average duration of diabetes was 9.1 ± 5.1 years. The mean BMI was 29.8± 5.9 kg/m2. Also, 315 (70%) of patients were hypertensive.
Low HDL-C was the most common form of dyslipidemia and was found in 311 (69.11%) The impact of gender on serum lipids is shown in Table 2 . Among circulating lipids, TC, LDL-C and TG were significantly higher in male patients (TC: p=0.011, LDL-C: p=0.002, TG: p=0.031). HDL-C was also slightly lower (p=0.033) in females as compared to males. The mean value of HbA1c and FBG were slightly higher in females in comparison to male patients, but the differences were not significant.
HbA1c demonstrated significant correlations with TC (r=0.40, p = 0.01), LDL-C (r =0.84; p=0.00) and LDLc/HDL-C ratio (r =0.3, p=0.01). The correlation of HbA1c with TG was positive (p=0. 16 ), but that with HDL-C was negative (p=0.00). HbA1c was found to be a predictor of hypercholesterolemia (p=0. Figure 1 . The biochemical parameters categorized by patients' glycemic control (HbA1c) are presented in Table 3 . Group II (Hb1Ac > 7.0%) had significantly higher values of TC (p = 0.024), TG (P=0.030), LDL-C (P=0.011), TC/HDL-C (p=0.001) and LDL-C/HDL-C (p=0.002) as compared to Group I (HbA1c ≤ 7.0%). 
Figure 1. Correlations between HbA1c, FBG and lipide profile parameters. (a) Positive correlation between HbA1c and FBG. (b) Positive correlation between TC and HbA1c. (c) Positive correlation between HbA1c and TG. (d) Negative correlation between HbA1c and HDL-c. (e) Positive correlation between HbA1c and LDL-c. (f) Positive correlation between LDL/ HDL ratio and HbA1c.

Discussion
In the present study, we evaluated the parameters of lipid profile in T2DM, and their correlation with HbA1c. HbA1c levels did not differ significantly between the two genders. However, there was a significant difference in the levels of lipid parameters between males and females ( Table 2) . Levels of TC, LDL-C and TG were significantly higher in men. These findings are consistent with those of previous studies [8] . Hyperlipidemia in females might be attributed to the effects of sex hormones on body fat distribution which lead to differences in altered lipoproteins [9] .
A recent study, including 120 T2DM patients reported a mean HbA1c significantly higher in diabetic patients with silent myocardial ischemia [10] . The current study revealed a high prevalence of hypercholesterolemia, hypertriglyceridemia, high LDL-C and low HDL-C levels which are all well known risk factors for cardiovascular disease. The results of our study and the reasons for dyslipidemia were comparable to a similar study reporting the patterns of diabetic dyslipidemia in Pakistani. They concluded that the pattern of dyslipidemia was characterized by high levels of LDL-C and low HDL-C [11].
Hyperglycemia and dyslipidemia generally coexist in diabetic patients with poor glucose control. The interaction of hyperglycemia and dyslipidemia increases the risk of macro-and micro-vascular complications [12] . The mechanisms by which hyperglycemia and dyslipidemia cause diabetic vascular diseases are the formation and accumulation of advanced glycation end products (AGEs) [13] , increased oxidative stress, activation of protein kinase C (PKC), increased flux through the hexosamine pathway, vascular inflammation, deficiency of insulin action in the vasculature, and altered expression and action of hormones, growth factors, and cytokines [14] . In addition, chemical modification of lipoprotein in diabetic states, including peroxidation and glycation, may be an underlying pathogenic mechanism linking dyslipidemia to diabetic complications. For instance, oxidation may increase atherogenicity of the lipoproteins, whereas glycation may enhance the oxidative stress of the lipoproteins. Furthermore, chemical modification of proteins by lipids, such as formation of lipoxidation end products, has also been suggested to be a likely pathogen for vascular changes in diabetes [15] .
HbA1c level of 7.0% is considered to be appropriate for reducing the risk of cardiovascular complications [16] . In the current study, diabetic patients with HbA1c > 7% had a Romanian Journal of Diabetes Nutrition & Metabolic Diseases / Vol. 23 / no. 2 / 2016 significant increase in TC, LDL-C, TG, TC/HDL-C and LDL-C/HDL-C ratio as compared to patients with HbA1c ≤ 7.0%. These results are similar to those of Chintamani et al. study [17] . Furthermore, Wagner and colleagues showed that the improvement in glycemic control from HbA1c of 10.54± 2.05% to HbA1c of 7.01 ±0.63% (P <0.0005) after a follow-up of 3.5 months resulted in a significant reduction in LDL-C -from 3.62± 1.15 to 3.34 ±1.02 mmol/L ( p <0.05), and apo B -from 1.17 ±0.29 to 1.07± 0.25 g/L (p <0.01), with increase in LDL particle size from 25.10± 0.31 to 25.61 ±0.53 nm (P<0.005) in T2DM patients who had LDL phenotype B at baseline [18] . Their findings clearly indicate that HbA1c can provide valuable information besides its primary role in monitoring long-term glycemic control. Thus, HbA1c can be used as a predictor of cardiovascular risk in diabetics [19] .
HbA1c abnormality indicates uncontrolled diabetes mellitus and dyslipidemia in diabetic patients and increases the risk of vascular complications. To prevent these complications, it is important to focus on HbA1c control and targeting lipids to avoid morbidity and mortality in diabetic patients. HbA1c measurement helps to control diabetes mellitus and helps identifying dyslipidemia [20] . In addition, another study reported that intensive glycemic control is associated with reduced cardiovascular events [21] . HbA1c is also used as a predictor of dyslipidemia in T2DM. [22] . HbA1c is associated with atherogenic dyslipidemia, particular TG and TG / HDL-C ratio, but not with TC, HDL-C or LDL-C [23] .
Our data reveal a prevalence of 51.3% of LDL-C levels higher than 100 mg/dl, which is considered a risk factor for CHD and atherosclerosis similar to the results of Ahmed et al. study [24] . On the other hand, low HDL-C was found to be the most prevalent lipid abnormality, which is also associated with high risk of CHD and atherosclerosis.
Most patients with T2DM have dyslipidemia in varying degrees. With the increased levels of HbA1c, dyslipidemia becomes more severe [25] . The estimation of cardiovascular disease risk was increased by 18% for each 1% increase in absolute HbA1c value in diabetic population [5] . HbA1c is directly related to the severity of coronary artery disease (CAD) in diabetic patients [9] . Whereas improving the glycemic control can substantially reduce the risk of cardiovascular events in diabetics is debatable. Moreover, attempts to reduce cardiovascular risks resulted in the improvement of HbA1c even in the absence of any specific intervention targeting improvement of glycemic control [26] . A soluble form of receptor for advanced glycation end products (SRAGE) in type 2 diabetic patients with CAD was found to be elevated with significant association between SRAGE and HbA1c as well as serum lipids [27] .
There were obvious limitations to our study, mainly being single centered and using a small sample size. Our study has also some strength since dyslipidemia is found frequently in patients with type 2 diabetes and seems to be correlated with glycemic control. Because it is a major risk factor for coronary heart disease, and one of the most important and frequent complications with a high premature mortality and morbidity rate, dyslipidemia should be better assessed, prevented, and treated as early as possible to avoid or reduce vascular damage.
Conclusion
This study showed a correlation between HbA1c and various lipid parameters or atherogenic ratios (LDL-C/HDL-C ratio). This suggests that with higher HbA1c values, the severity of dyslipidemia increases in T2DM patients. Therefore, diabetic patients with elevated HbA1c and dyslipidemia can be considered as a very high risk group for cardiovascular diseases. Our results suggest that HbA1c may be used as indicator for early diagnosis of dyslipidemia in addition to its primary role in monitoring long-term glycemic control (HbA1c has the potential of being a dual biomarker).
